ArticleCancers2023

Comparative Analysis of Atezolizumab Plus Bevacizumab and Hepatic Artery Infusion Chemotherapy in Unresectable Hepatocellular Carcinoma: A Multicenter, Propensity Score Study.

Ji Hoon Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.